Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Solomon, Cohney"'
Autor:
Joshua Kausman, Erica M. Wood, Lucy C. Fox, Anne M. Durkan, Nicole M. Isbel, Jake Shortt, Peter Hughes, Solomon Cohney, Piers Blombery, Pravin Hissaria, Thomas D. Barbour, Theo de Malmanche
Publikováno v:
Internal Medicine Journal. 48:624-636
Thrombotic microangiopathy (TMA) arises in a variety of clinical circumstances with the potential to cause significant dysfunction of the kidneys, brain, gastrointestinal tract and heart. TMA should be considered in all patients with thrombocytopenia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7140d4e8d08a3c35ba38d8b9627076a9
https://doi.org/10.1111/imj.13804
https://doi.org/10.1111/imj.13804
Autor:
Erica M. Wood, Theo de Malmanche, Thomas D. Barbour, Joshua Kausman, Piers Blombery, Anne M. Durkan, Jake Shortt, Lucy C. Fox, Solomon Cohney, Nicole M. Isbel, Peter Hughes, Pravin Hissaria
Publikováno v:
Nephrology. 23:507-517
Thrombotic microangiopathy (TMA) arises in a variety of clinical circumstances with the potential to cause significant dysfunction of the kidneys, brain, gastrointestinal tract and heart. TMA should be considered in all patients with thrombocytopenia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70e19cac62044edec5672d23afe1cfd4
https://doi.org/10.1111/nep.13234
https://doi.org/10.1111/nep.13234
Autor:
Solomon Cohney, Maurizio Cassader, Giovanni Musso, Franco De Michieli, Roberto Gambino, Francesca Saba, Silvia Pinach
Publikováno v:
Diabetes Care. 39:1830-1845
Chronic kidney disease (CKD) is a risk factor for end-stage renal disease (ESRD) and cardiovascular disease (CVD). ESRD or CVD develop in a substantial proportion of patients with CKD receiving standard-of-care therapy, and mortality in CKD remains u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f4f636024c8281662cf4cf477c0603e
https://doi.org/10.2337/dc15-1182
https://doi.org/10.2337/dc15-1182
Autor:
Andrew Bentall, Solomon Cohney
Publikováno v:
American Journal of Transplantation. 17:3003-3005
In this week's journal, Axelrod and colleagues examine costs incurred by various US centers undertaking Incompatible Live-Donor Kidney Transplantation (ILDKT) – living donor renal transplantation in the presence of preformed antibody (ies) directed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffbaa0cbbc22985c4331a09db55e2643
https://doi.org/10.1111/ajt.14494
https://doi.org/10.1111/ajt.14494
Autor:
Piers Blombery, Zoe McQuilten, Erica M. Wood, L. Kivivali, Sunelle Engelbrecht, D. Pepperell, Mark N. Polizzotto, Louise Elizabeth Phillips, Solomon Cohney
Publikováno v:
Internal Medicine Journal. 46:71-79
Background Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy (TMA). In 2009, the Australian TTP/TMA registry was established to collect data on patients presenting with TTP/TMA throughout Australia. Aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe1d6ce1287b1dc9e9e7bd03069a6a41
https://doi.org/10.1111/imj.12935
https://doi.org/10.1111/imj.12935
Autor:
Solomon Cohney, Christopher J Yates
Publikováno v:
Current Diabetes Reviews. 11:170-174
The identification of at-risk individuals prior to transplantation may enable implementation of measures to prevent or delay PTDM development, while early detection facilitates prompt management and may prevent acute and chronic complications. Thus,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63075e201a85b59feddcb19d63033ebf
https://doi.org/10.2174/1573399811999150316105553
https://doi.org/10.2174/1573399811999150316105553
Autor:
Solomon Cohney, Nancy Suh, Rowan G. Walker, Michael N Haeusler, Amanda Robertson, Chris Hogan, Peter Hughes, Rosemary Masterson, R. J. Millar
Publikováno v:
American Journal of Transplantation. 14:2807-2813
ABO incompatible living donor renal transplantation (ABOi) can achieve outcomes comparable to ABO compatible transplantation (ABOc). However, with the exception of blood group A2 kidneys transplanted into recipients with low titer anti-A antibody, re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f5914d1c403e76ecaa5aa84ef720ca
https://doi.org/10.1111/ajt.12920
https://doi.org/10.1111/ajt.12920
Autor:
Moira Finlay, Solomon Cohney, Peter Hughes, A. Crosthwaite, Thomas D. Barbour, Nathan Better, Kevin V. Chow
Publikováno v:
Nephrology. 19:177-185
Antiphospholipid syndrome (APS) may occur in isolation or in association with systemic lupus erythematosus (SLE), with the potential to cause renal failure via several distinct pathologies. Renal transplantation in the presence of APS carries a risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b9305c96cc3e5bbaf3dc863a6c689a8
https://doi.org/10.1111/nep.12217
https://doi.org/10.1111/nep.12217
Publikováno v:
Nephrology Dialysis Transplantation. 29:698-705
Background. Prednisolone is a major risk factor for hyperglycaemia and new-onset diabetes after transplantation. Uncontrolled observational data suggest that divided dosing may reduce requirements for hypoglycaemic agents. This study aims to compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ab9cd4efdd4035d8fa8db26486148fa
https://doi.org/10.1093/ndt/gft377
https://doi.org/10.1093/ndt/gft377
Autor:
Mark Holmes, Bronwyn Levvey, A. Shipp, Gregory I Snell, Solomon Cohney, Colin F. Robertson, Glen P. Westall
Publikováno v:
American Journal of Transplantation. 13:1350-1353
With ABO blood group incompatibility (ABOi) between donor and recipient becoming a part of mainstream living-donor renal transplantation, the applicability of ABOi to other areas of transplantation is being reconsidered. Here we present a case of ina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8e61d7bb738b4ff789109865d8bb113
https://doi.org/10.1111/ajt.12185
https://doi.org/10.1111/ajt.12185